Lactoferrin Administration into the Nostril Alleviates Murine Allergic Rhinitis and its Mechanisms

Scandinavian Journal of Immunology

Volumn 78, Issue 6, 2013, Pages 507-515

  Wang, S B ^a,b   Deng, Y Q ^a   Ren, J ^a   Xiao, B K ^a   Chen, Z ^a   Tao, Z Z ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 5; LACTOFERRIN; MESSENGER RNA; OVALBUMIN; RECOMBINANT HUMAN LACTOFERRIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHIL; GOBLET CELL; HISTOLOGY; INFLAMMATION; MOUSE; NASAL LAVAGE; NONHUMAN; NOSE; NOSE CAVITY; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL; TH2 CELL; UPREGULATION;

ADMINISTRATION, INTRANASAL; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; GOBLET CELLS; INFLAMMATION; LACTOFERRIN; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; OVALBUMIN; RHINITIS, ALLERGIC, PERENNIAL; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84888405764     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12118     Document Type: Article

References (35)

1. Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics 2004;22:345-61.
2. Ishigame H, Kakuta S, Nagai T et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009;30:108-19.
3. Quan SH, Zhang YL, Han DH, Iwakura Y, Rhee CS. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model. Ann Allergy Asthma Immunol 2012;108:342-50.
4. Mo JH, Kang EK, Quan SH, Rhee CS, Lee CH, Kim DY. Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model. Allergy 2011;66:279-86.
5. Malmhall C, Bossios A, Pullerits T, Lotvall J. Effects of pollen and nasal glucocorticoid on FOXP3 + , GATA-3 + and T-bet+ cells in allergic rhinitis. Allergy 2007;62:1007-13.
6. El-Naggar MM, Ukai K, Takeuchi K, Sakakura Y. Expression of interferon-gamma, interleukin-4 and interleukin-5 mRNA in the nasal mucosal membrane of rats with allergic rhinitis. Scand J Immunol 1998;47:554-60.
7. Lu Y, Sjostrand M, Malmhall C et al. New production of eosinophils and the corresponding TH1/TH2 balance in the lungs after allergen exposure in BALB/c and C57BL/6 mice. Scand J Immunol 2010;71:176-85.
8. Josefowicz SZ, Niec RE, Kim HY et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012;482:395-9.
9. Han D, Wang C, Lou W, Gu Y, Wang Y, Zhang L. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis. Clin Immunol 2010;136:292-301.
10. Frati F, Incorvaia C, Lombardi C, Senna G. Allergen immunotherapy: 100 years, but it does not look like. Eur Ann Allergy Clin Immunol 2012;44:99-106.
11. Andersen JH. Technology evaluation: rh lactoferrin, Agennix. Curr Opin Mol Ther 2004;6:344-9.
12. Zimecki M, Kruzel ML. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice. Immunol Lett 2000;74:183-8.
13. de la Rosa G, Yang D, Tewary P, Varadhachary A, Oppenheim JJ. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J Immunol 2008;180:6868-76.
14. Berlutti F, Pantanella F, Natalizi T et al. Antiviral properties of lactoferrin-a natural immunity molecule. Molecules 2011;16:6992-7018.
15. Deng M, Zhang W, Tang H et al. Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms. Oncogene 2012; 32: 4273-83.
16. Elrod KC, Moore WR, Abraham WM, Tanaka RD. Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am J Respir Crit Care Med 1997;156:375-81.
17. Bournazou I, Mackenzie KJ, Duffin R, Rossi AG, Gregory CD. Inhibition of eosinophil migration by lactoferrin. Immunol Cell Biol 2010;88:220-3.
18. Kruzel ML, Bacsi A, Choudhury B, Sur S, Boldogh I. Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology 2006;119:159-66.
19. Chodaczek G, Saavedra-Molina A, Bacsi A, Kruzel ML, Sur S, Boldogh I. Iron-mediated dismutation of superoxide anion augments antigen-induced allergic inflammation: effect of lactoferrin. Postepy Hig Med Dosw (Online) 2007;61:268-76.
20. Choi GS, Shin SY, Kim JH et al. Serum lactoferrin level as a serologic biomarker for allergic rhinitis. Clin Exp Allergy 2010;40:403-10.
21. Fischer R, Debbabi H, Dubarry M, Boyaka P, Tome D. Regulation of physiological and pathological Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin responses by lactoferrin. Biochem Cell Biol 2006;84:303-11.
22. Wang H, Lu X, Cao PP et al. Histological and immunological observations of bacterial and allergic chronic rhinosinusitis in the mouse. Am J Rhinol 2008;22:343-8.
23. Spik G, Legrand D, Leveugle B et al. Characterization of two kinds of lactotransferrin (lactoferrin) receptors on different target cells. Adv Exp Med Biol 1994;357:13-9.
24. Bi BY, Leveugle B, Liu JL et al. Immunolocalization of the lactotransferrin receptor on the human T lymphoblastic cell line Jurkat. Eur J Cell Biol 1994;65:164-71.
25. Mincheva-Nilsson L, Hammarstrom S, Hammarstrom ML. Activated human gamma delta T lymphocytes express functional lactoferrin receptors. Scand J Immunol 1997;46:609-18.
26. Ghio AJ, Carter JD, Dailey LA, Devlin RB, Samet JM. Respiratory epithelial cells demonstrate lactoferrin receptors that increase after metal exposure. Am J Physiol 1999;276:L933-40.
27. Hwang SA, Wilk KM, Bangale YA, Kruzel ML, Actor JK. Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med Microbiol Immunol 2007;196:171-80.
28. Zhao LL, Lotvall J, Linden A, Tomaki M, Sjostrand M, Bossios A. Prolonged eosinophil production after allergen exposure in IFN-gammaR KO mice is IL-5 dependent. Scand J Immunol 2008;67:480-8.
29. Lee SS, Won TB, Kim JW et al. Effects of Dexamethasone on the Expression of Transforming Growth Factor-βin the Mouse Model of Allergic Rhinitis. Laryngoscope 2007;117:1323-8.
30. Ouyang YH, Miyata M, Hatsushika K et al. TGF-β Signaling May Play a Role in the Development of Goblet Cell Hyperplasia in a Mouse Model of Allergic Rhinitis. Allergol Int 2010;59:1-7.
31. Burgler S, Ouaked N, Bassin C et al. Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol 2009;123:588-95.
32. Kim B, Kang S, Kim SJ. Genome-wide pathway analysis reveals different signaling pathways between secreted lactoferrin and intracellular delta-lactoferrin. PLoS ONE 2013;8:e55338.
33. Psaltis AJ, Wormald PJ, Ha KR, Tan LW. Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis. Laryngoscope 2008;118:895-901.
34. Psaltis AJ, Bruhn MA, Ooi EH, Tan LW, Wormald PJ. Nasal mucosa expression of lactoferrin in patients with chronic rhinosinusitis. Laryngoscope 2007;117:2030-5.
35. Roca-Ferrer J, Mullol J, Perez M et al. Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: comparison between human upper and lower airways. J Allergy Clin Immunol 2000;106:1053-62.